...
首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Evaluation of fetal fibronectin rapid bedside test as a predictor of preterm labour: a prospective study
【24h】

Evaluation of fetal fibronectin rapid bedside test as a predictor of preterm labour: a prospective study

机译:评估胎儿纤连蛋白快速床旁试验作为早产预测指标:一项前瞻性研究

获取原文

摘要

Background: Preterm birth defined as birth before 37 weeks of gestation is a significant public health issue. Identification of patients at risk of preterm labour while ruling out those who are not is a fundamental but challenging goal for clinicians. This study was done to evaluate bed side dipstick test for detecting fetal fibronectin in cervico-vaginal secretions as a predictor of preterm delivery in symptomatic and asymptomatic high risk group. Methods: This was a hospital based prospective, double blinded study. We enrolled 100 pregnant women presenting with or without symptoms of preterm delivery, between 20 and 35 weeks of gestation. A rapid bed side dipstick test was performed to detect FFN in cervico-vaginal secretions of all enrolled women (symptomatic and asymptomatic high risk women) and results were evaluated for prediction of preterm labour. Qualitative data were analyzed by using Chi-square and Fisher’s exact test and quantitative data were analyzed by using unpaired Student’s t test and Mann-Whitney test. P value 0.05 was considered significant. Results: In symptomatic group sensitivity, specificity, PPV and NPV of FFN test in predicting delivery within 48 hours, 7days 14days and preterm delivery was 100%, 63.2%, 46.2%, 100%; 100%, 72.7%, 65.4%, 100%; 100%, 75%, 69.2%, 100%; 80%, 76%, 76.9%, 79.2% respectively. In asymptomatic high risk group, sensitivity, specificity, PPV and NPV of FFN test in predicting preterm delivery (37weeks) was 0%, 87.5%, 0%, 77.8%. Conclusions: The high negative predictive value may be of value in avoiding unnecessary interventions with potentially hazardous medications and identifying symptomatic women who are not in true labour and also allaying anxiety of asymptomatic high risk women.
机译:背景:早产定义为妊娠37周之前出生是一个重大的公共卫生问题。对于临床医生来说,识别有早产风险的患者并排除那些不是早产患者是一个基本但具有挑战性的目标。这项研究旨在评估床旁试纸法检测宫颈阴道分泌物中的胎儿纤连蛋白,作为有症状和无症状高危组早产的预测指标。方法:这是一项基于医院的前瞻性,双盲研究。我们招募了100名孕妇,这些孕妇在妊娠20至35周之间有或没有早产症状。进行了快速床旁试纸测试,以检测所有入组女性(有症状和无症状高危女性)宫颈阴道分泌物中的FFN,并对结果进行评估以预测早产。定性数据通过卡方检验和Fisher精确检验进行分析,定量数据通过不成对的Student t检验和Mann-Whitney检验进行分析。 P值<0.05被认为是显着的。结果:在症状组敏感性,FFN检测的特异性,PPV和NPV在预测48小时,7天,14天和早产中的分娩率分别为100%,63.2%,46.2%,100%; 100%,72.7%,65.4%,100%; 100%,75%,69.2%,100%;分别为80%,76%,76.9%和79.2%。在无症状高危组中,FFN检测在预测早产(<37周)时的敏感性,特异性,PPV和NPV分别为0%,87.5%,0%,77.8%。结论:较高的阴性预测价值可能对避免不必要的潜在危险药物干预,识别未从事真正分娩的有症状女性以及缓解无症状高危女性的焦虑具有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号